Our teams, facility and working environment are geared towards making the innovation faster, efficient and successful. As a drug discovery incubator, IBS is armed with experience, scientific tools, computer aided drug designing, expertise in chemistry, analytical instrumentation, in-vitro pharmacology and ADME.Dedicated teams include the best and brightest talent trained at Indian/International elite universities for which achieving the scientific goals is the sole priority.Integral Biosciences (IBS) is a Delhi-based Indian biotech company, which operates on a hybrid business model. IBS has capabilities to support medicinal chemistry, in-vitro screening and initial DMPK characterization of compounds...Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of Brutons Tyrosine Kinase and Phosphoinositide 3-Kinase p110, ACS Medicinal Chemistry Letters (2016).Integral Biosciences (IBS) is a Delhi-based Indian biotech company, which operates a hybrid business model. IBS has capabilities to support medicinal chemistry, in-vitro screening and initial DMPK characterization of compounds...Discovery of Pyrazolopyrimidine Derivatives as Novel Dual Inhibitors of Brutons Tyrosine Kinase and Phosphoinositide 3-Kinase p110, ACS Medicinal Chemistry Letters (2016). C-64, HOSEIRY COMPLEX NOIDA PHASE-II, EXTENSION, NOIDA 201306
CORELOGS